Related Experiment Video

Updated: Apr 12, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.9K

Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human Studies

Giorgia Zadra1, Julie L Batista2, Massimo Loda3

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, Massachusetts. Department of Pathology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, Massachusetts.

Molecular Cancer Research : MCR
|May 10, 2015
PubMed

Insights

5'AMP-activated kinase (AMPK) has a complex role in cancer, acting as both a tumor suppressor and oncogene. Its activation impacts cancer cell survival and proliferation, with varying effects depending on the tumor context.

Area of Science:

  • Biochemistry
  • Oncology
  • Metabolic Regulation

Background:

  • 5'AMP-activated kinase (AMPK) is a key cellular energy sensor.
  • AMPK's role in cancer is complex and context-dependent, with dual functions.
  • Its activation influences cancer cell proliferation, growth, and survival under metabolic stress.

Purpose of the Study:

  • To review the multifaceted roles of AMPK in cancer.
  • To discuss the therapeutic implications of modulating AMPK activity.
  • To provide an overview of human studies on AMPK activation and related drugs.

Main Methods:

  • Literature review of AMPK's function in cancer.
  • Analysis of data on AMPK activation in human cancer tissues.
  • Examination of clinical studies involving AMPK-activating drugs.

Main Results:

  • AMPK activation inhibits anabolic processes crucial for cancer growth.
  • AMPK confers plasticity, enabling cancer cell survival under metabolic stress (hypoxia, glucose deprivation).
  • AMPK's impact on tumor aggressiveness and progression varies across different cancer types and contexts.

Conclusions:

  • AMPK is a "contextual" oncogene and "conditional" tumor suppressor in cancer.
  • Modulating AMPK offers potential therapeutic strategies, but requires careful consideration of context.
  • Further research and clinical studies are needed to fully elucidate AMPK's therapeutic potential in oncology.

More Related Videos

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.5K
Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines06:00

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Published on: September 13, 2017

7.7K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
8.0K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.4K